<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Pharmaceutical Product Guide &#187; warning letter</title>
	<atom:link href="http://www.pharmaceuticalproductguide.com/blog/tag/warning-letter/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.pharmaceuticalproductguide.com/blog</link>
	<description>A comprehensive guide to pharmaceutical products for medical professionals</description>
	<lastBuildDate>Fri, 11 Jun 2010 09:15:33 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.2</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>FDA warning letter to Baxa</title>
		<link>http://www.pharmaceuticalproductguide.com/blog/2008/05/13/fda-warning-letter-to-baxa/</link>
		<comments>http://www.pharmaceuticalproductguide.com/blog/2008/05/13/fda-warning-letter-to-baxa/#comments</comments>
		<pubDate>Tue, 13 May 2008 17:25:18 +0000</pubDate>
		<dc:creator>Kimberly O'Brien</dc:creator>
				<category><![CDATA[FDA Approval]]></category>
		<category><![CDATA[Baxa]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[MDR]]></category>
		<category><![CDATA[medical device]]></category>
		<category><![CDATA[serious injuries]]></category>
		<category><![CDATA[user error]]></category>
		<category><![CDATA[warning letter]]></category>

		<guid isPermaLink="false">http://www.pharmaceuticalproductguide.com/blog/2008/05/13/fda-warning-letter-to-baxa/</guid>
		<description><![CDATA[Baxa has been issued a warning letter by the FDA for failing to report two complaints in which the patients suffered serious injuries due to incorrect concentration administration of solutions caused by user error. The medical device reporting (MDR) requirements are very specific on the need for such events being reported.
]]></description>
			<content:encoded><![CDATA[<p><img border="0" vspace="5" align="left" width="96" src="http://www.pharmaceuticalproductguide.com/blog/wp-content/uploads/2008/05/baxa.png" hspace="5" alt="Baxa" height="60" /><a href="http://www.baxa.com">Baxa</a> has been issued a warning letter by the FDA for failing to report two complaints in which the patients suffered serious injuries due to incorrect concentration administration of solutions caused by user error. The medical device reporting (MDR) requirements are very specific on the need for such events being reported.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.pharmaceuticalproductguide.com/blog/2008/05/13/fda-warning-letter-to-baxa/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
